The crucially important work is accomplished through deploying S&T’s advanced lab-based technical expertise and capabilities in research, development, test and evaluation (RDT&E).
UCI materials scientists discover design secrets of nearly indestructible insect
Irvine, Calif., Oct. 21, 2020 – With one of the more awe-inspiring names in the animal kingdom, the diabolical ironclad beetle is one formidable insect. Birds, lizards and rodents frequently try to make a meal of it but seldom succeed. Run over it with a car, and the critter lives on. The beetle’s survival depends on two key factors: its ability to convincingly play dead and an exoskeleton that’s one of the toughest, most crush-resistant structures known to exist in the biological world.
New Device Can Measure Toxic Lead Within Minutes
Rutgers researchers have created a miniature device for measuring trace levels of toxic lead in sediments at the bottom of harbors, rivers and other waterways within minutes – far faster than currently available laboratory-based tests, which take days. The affordable lab-on-a-chip device could also allow municipalities, water companies, universities, K-12 schools, daycares and homeowners to easily and swiftly test their water supplies. The research is published in the IEEE Sensors Journal.
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.
New Rutgers Saliva Test for Coronavirus Gets FDA Approval
The FDA has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. The new saliva collection method, which RUCDR developed in partnership with Spectrum Solutions and Accurate Diagnostic Labs (ADL), will allow for broader population screening than the current method of nose and throat swabs.